Latest Varian Medical Systems Inc. Stories
Net earnings per diluted share were $1.02 for the fourth quarter and $3.83 for fiscal year 2014; revenues were $812 million for the fourth quarter and $3 billion for the fiscal year; backlog rises
PALO ALTO, Calif., Oct. 14, 2014 /PRNewswire/ -- Varian Medical Systems (NYSE: VAR) announced today that its management will hold a year-end review for investors from 11:30 a.m.
PALO ALTO, Calif., Oct.
Infor's Cloverleaf Integration Engine to enhance the security, interoperability, and performance of Varian's oncology software solutions NEW YORK and PALO ALTO, Calif., Sept.
ProBeam version 2.5 successfully installed to enhance workflow at the San Diego site; technology is on display at the ASTRO meeting in San Francisco SAN FRANCISCO, Sept.
Varian's Eclipse(TM) treatment planning software can now be used to plan mARC treatments at sites using Siemens medical linear accelerators SAN FRANCISCO, Sept.
Varian will also showcase the company's full range of radiotherapy and radiosurgery solutions, including tools for real-time imaging, tumor tracking, and motion management SAN FRANCISCO, Sept.
New tool designed to empower users of the ARIA® oncology information system for radiation oncology to analyze data and use metrics to help make more informed decisions SAN FRANCISCO,
PALO ALTO, Calif., Sept.
- In medieval musical notation, a sign or neume denoting a shake or trill.